Journal of Psychoactive Drugs
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q2 | 61.6% | 0.700 | Q2 | 72.9% |
| 2024 | 2.2 | Q2 | 58.4% | 0.833 | Q2 | 79.1% |
| 2023 | 2.1 | Q3 | 44.4% | 0.766 | Q2 | 78.4% |
| 2022 | 2.8 | Q2 | 50.0% | 0.946 | Q1 | 85.0% |
| 2021 | 3.3 | Q3 | 48.0% | 0.651 | Q2 | 75.4% |
| 2020 | — | — | 0.689 | Q2 | 75.7% | |
| 2019 | — | — | 0.588 | Q2 | 72.1% | |
| 2018 | — | — | 0.746 | Q2 | 76.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2159-9777
ISSN
0279-1072
country
GBcoverage
1967-1972, 1974-2026